Search results

• 2023

  Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom

  The Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study group, The Guy's and St Thomas' Oesophago-gastric Research Group, The PROGRESS study group, Cominos, M., Sevitt, T., Hynes, O., Tham, G. & Zeki, S. S., 1 Oct 2023, In: Journal of Clinical Oncology. 41, 28, p. 4522-4534 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophageal Adenocarcinoma 100%
  • Lymph Node 100%
  • Recurrent Disease 100%
  • Neoadjuvant Chemotherapy 100%
  • Patient 19%
  14 Citations (Scopus)